Many Americans Use GLP

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-22T17:35:55.373Z • Permanent link

Regulatory scrutiny is intensifying in the United States, with a recent study revealing that over 1 million Americans are using weight-loss drugs without medical supervision. The investigation, conducted by the National Institutes of Health (NIH), sheds light on the growing trend of self-medication, particularly among women. Data from the Centers for Disease Control and Prevention (CDC) indicates that the number of Americans taking weight-loss medications has risen significantly over the past decade, with women accounting for more than 70% of all users.

Pharmaceutical giants such as Pfizer and Johnson & Johnson have seen their sales soar, thanks in part to the growing demand for weight-loss medications. However, experts warn that this trend is not only a concern for public health but also a threat to the integrity of the pharmaceutical industry. A recent report by the Congressional Budget Office (CBO) estimates that the US government will spend over $2 billion on weight-loss medications in 2023 alone, with costs projected to reach $5 billion by 2025.

Critics argue that the pharmaceutical industry's aggressive marketing tactics have contributed to the rise in self-medication. A study published in the Journal of the American Medical Association (JAMA) found that pharmaceutical companies have spent millions of dollars on advertising and promotional activities targeting consumers, often with misleading or unsubstantiated claims about the effectiveness of their products.

Tensions between the pharmaceutical industry and regulatory agencies have been escalating in recent years, with some critics accusing the industry of exploiting loopholes in the law to market their products more aggressively. The 21st Century Cures Act of 2016, signed into law by President Barack Obama, provided significant funding for the NIH and other research institutions, but critics argue that the law also gave pharmaceutical companies too much leeway to market their products.

Regulatory bodies in the US have long been grappling with the issue of self-medication, particularly in the context of opioid abuse. The opioid crisis has highlighted the need for more effective regulations on the pharmaceutical industry, but efforts to reform the industry have been slow to materialize. A recent report by the Government Accountability Office (GAO) found that the FDA has been criticized for its handling of opioid-related issues, with some critics arguing that the agency has been too lenient on pharmaceutical companies.

Experts are warning that the trend of self-medication is likely to continue, driven in part by the growing demand for convenient and affordable healthcare solutions. The rise of telemedicine and online pharmacies has made it easier for consumers to access weight-loss medications, often without the need for a doctor's prescription. However, this trend also poses significant risks, including the potential for adverse reactions and the spread of counterfeit or unregulated medications.